What is Arbutus Biopharma Corporation Common Stock's Market Cap?

Arbutus Biopharma Corporation Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Enterprise Value?

Arbutus Biopharma Corporation Common Stock's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Trailing P/E?

Arbutus Biopharma Corporation Common Stock's Trailing P/E is 6.8×, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Price / Sales?

Arbutus Biopharma Corporation Common Stock's Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's EV / Revenue?

Arbutus Biopharma Corporation Common Stock's EV / Revenue is 5.6×, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's EV / EBITDA?

Arbutus Biopharma Corporation Common Stock's EV / EBITDA is 6.7×, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Revenue (TTM)?

Arbutus Biopharma Corporation Common Stock's Revenue (TTM) is $181.7M, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Net Income (TTM)?

Arbutus Biopharma Corporation Common Stock's Net Income (TTM) is $153.1M, based on as-reported figures from SEC (XBRL) filings.

What is Arbutus Biopharma Corporation Common Stock's Diluted EPS (TTM)?

Arbutus Biopharma Corporation Common Stock's Diluted EPS (TTM) is 0.77, based on as-reported figures from SEC (XBRL) filings.

Arbutus Biopharma Corporation Common Stock (ABUS) Financial Statements

Arbutus Biopharma Corporation Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S6RSK0

XNAS · usd

5.23▲ 0.05 (0.97%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close5.18

Day's Range5.08 – 5.20

52-Week Range3.50 – 5.45

Volume5.3M

Avg Volume3.4M

Share Statistics

Shares Outstanding

Employees19

ExchangeXNAS

Listed2007-07-26

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Arbutus Biopharma Corporation Common Stock (ABUS)

What is Arbutus Biopharma Corporation Common Stock's Market Cap?: Arbutus Biopharma Corporation Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Enterprise Value?: Arbutus Biopharma Corporation Common Stock's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Trailing P/E?: Arbutus Biopharma Corporation Common Stock's Trailing P/E is 6.8×, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Price / Sales?: Arbutus Biopharma Corporation Common Stock's Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's EV / Revenue?: Arbutus Biopharma Corporation Common Stock's EV / Revenue is 5.6×, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's EV / EBITDA?: Arbutus Biopharma Corporation Common Stock's EV / EBITDA is 6.7×, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Revenue (TTM)?: Arbutus Biopharma Corporation Common Stock's Revenue (TTM) is $181.7M, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Net Income (TTM)?: Arbutus Biopharma Corporation Common Stock's Net Income (TTM) is $153.1M, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's EBITDA?: Arbutus Biopharma Corporation Common Stock's EBITDA is $149.4M, based on as-reported figures from SEC (XBRL) filings.
What is Arbutus Biopharma Corporation Common Stock's Diluted EPS (TTM)?: Arbutus Biopharma Corporation Common Stock's Diluted EPS (TTM) is 0.77, based on as-reported figures from SEC (XBRL) filings.